SPIL-1033
- Generic Name
- SPIL-1033
Safety and Efficacy of SPIL1033 in Subjects With Type 2 Diabetes Mellitus
- First Posted Date
- 2011-08-01
- Last Posted Date
- 2020-08-11
- Lead Sponsor
- Sun Pharmaceutical Industries Limited
- Target Recruit Count
- 360
- Registration Number
- NCT01406717
- Locations
- 🇮🇳
SPIL Site 26, Hyderabad, Andhra Pradesh, India
🇮🇳SPIL Site 2, Ahmedabad, Gujrat, India
🇮🇳SPIL Site 7, Surat, Gujrat, India
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath